713 related articles for article (PubMed ID: 1375259)
1. Lymphocyte adhesion through very late antigen 4: evidence for a novel binding site in the alternatively spliced domain of vascular cell adhesion molecule 1 and an additional alpha 4 integrin counter-receptor on stimulated endothelium.
Vonderheide RH; Springer TA
J Exp Med; 1992 Jun; 175(6):1433-42. PubMed ID: 1375259
[TBL] [Abstract][Full Text] [Related]
2. Activation dependent and independent VLA-4 binding sites on vascular cell adhesion molecule-1.
Needham LA; Van Dijk S; Pigott R; Edwards RM; Shepherd M; Hemingway I; Jack L; Clements JM
Cell Adhes Commun; 1994 Jun; 2(2):87-99. PubMed ID: 7521763
[TBL] [Abstract][Full Text] [Related]
3. A monoclonal antibody to beta 1 integrin (CD29) stimulates VLA-dependent adherence of leukocytes to human umbilical vein endothelial cells and matrix components.
Kovach NL; Carlos TM; Yee E; Harlan JM
J Cell Biol; 1992 Jan; 116(2):499-509. PubMed ID: 1370496
[TBL] [Abstract][Full Text] [Related]
4. Domains 1 and 4 of vascular cell adhesion molecule-1 (CD106) both support very late activation antigen-4 (CD49d/CD29)-dependent monocyte transendothelial migration.
Chuluyan HE; Osborn L; Lobb R; Issekutz AC
J Immunol; 1995 Sep; 155(6):3135-4. PubMed ID: 7545712
[TBL] [Abstract][Full Text] [Related]
5. Activated endothelium binds lymphocytes through a novel binding site in the alternately spliced domain of vascular cell adhesion molecule-1.
Osborn L; Vassallo C; Benjamin CD
J Exp Med; 1992 Jul; 176(1):99-107. PubMed ID: 1377228
[TBL] [Abstract][Full Text] [Related]
6. ICAM-3 regulates lymphocyte morphology and integrin-mediated T cell interaction with endothelial cell and extracellular matrix ligands.
Campanero MR; Sánchez-Mateos P; del Pozo MA; Sánchez-Madrid F
J Cell Biol; 1994 Nov; 127(3):867-78. PubMed ID: 7525599
[TBL] [Abstract][Full Text] [Related]
7. Adhesion molecule mechanisms mediating monocyte migration through synovial fibroblast and endothelium barriers: role for CD11/CD18, very late antigen-4 (CD49d/CD29), very late antigen-5 (CD49e/CD29), and vascular cell adhesion molecule-1 (CD106).
Shang XZ; Lang BJ; Issekutz AC
J Immunol; 1998 Jan; 160(1):467-74. PubMed ID: 9552005
[TBL] [Abstract][Full Text] [Related]
8. Role of LFA-1 and VLA-4 in the adhesion of cloned normal and LFA-1 (CD11/CD18)-deficient T cells to cultured endothelial cells. Indication for a new adhesion pathway.
Vennegoor CJ; van de Wiel-van Kemenade E; Huijbens RJ; Sanchez-Madrid F; Melief CJ; Figdor CG
J Immunol; 1992 Feb; 148(4):1093-101. PubMed ID: 1371131
[TBL] [Abstract][Full Text] [Related]
9. Arrangement of domains, and amino acid residues required for binding of vascular cell adhesion molecule-1 to its counter-receptor VLA-4 (alpha 4 beta 1).
Osborn L; Vassallo C; Browning BG; Tizard R; Haskard DO; Benjamin CD; Dougas I; Kirchhausen T
J Cell Biol; 1994 Feb; 124(4):601-8. PubMed ID: 7508942
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of eosinophil adherence to cultured vascular endothelial cells. Eosinophils bind to the cytokine-induced ligand vascular cell adhesion molecule-1 via the very late activation antigen-4 integrin receptor.
Dobrina A; Menegazzi R; Carlos TM; Nardon E; Cramer R; Zacchi T; Harlan JM; Patriarca P
J Clin Invest; 1991 Jul; 88(1):20-6. PubMed ID: 1711540
[TBL] [Abstract][Full Text] [Related]
11. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site.
Elices MJ; Osborn L; Takada Y; Crouse C; Luhowskyj S; Hemler ME; Lobb RR
Cell; 1990 Feb; 60(4):577-84. PubMed ID: 1689216
[TBL] [Abstract][Full Text] [Related]
12. Human eosinophil adherence to vascular endothelium mediated by binding to vascular cell adhesion molecule 1 and endothelial leukocyte adhesion molecule 1.
Weller PF; Rand TH; Goelz SE; Chi-Rosso G; Lobb RR
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7430-3. PubMed ID: 1714604
[TBL] [Abstract][Full Text] [Related]
13. Tumor cell surface alpha 4 beta 1 integrin mediates adhesion to vascular endothelium: demonstration of an interaction with the N-terminal domains of INCAM-110/VCAM-1.
Taichman DB; Cybulsky MI; Djaffar I; Longenecker BM; Teixidó J; Rice GE; Aruffo A; Bevilacqua MP
Cell Regul; 1991 May; 2(5):347-55. PubMed ID: 1716464
[TBL] [Abstract][Full Text] [Related]
14. Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells.
Carlos TM; Schwartz BR; Kovach NL; Yee E; Rosa M; Osborn L; Chi-Rosso G; Newman B; Lobb R
Blood; 1990 Sep; 76(5):965-70. PubMed ID: 1697486
[TBL] [Abstract][Full Text] [Related]
15. Functional evidence for three distinct and independently inhibitable adhesion activities mediated by the human integrin VLA-4. Correlation with distinct alpha 4 epitopes.
Pulido R; Elices MJ; Campanero MR; Osborn L; Schiffer S; García-Pardo A; Lobb R; Hemler ME; Sánchez-Madrid F
J Biol Chem; 1991 Jun; 266(16):10241-5. PubMed ID: 1709929
[TBL] [Abstract][Full Text] [Related]
16. VLA-4 (alpha(4)beta(1)) engagement defines a novel activation pathway for beta(2) integrin-dependent leukocyte adhesion involving the urokinase receptor.
May AE; Neumann FJ; Schömig A; Preissner KT
Blood; 2000 Jul; 96(2):506-13. PubMed ID: 10887112
[TBL] [Abstract][Full Text] [Related]
17. Endothelial cell E- and P-selectin and vascular cell adhesion molecule-1 function as signaling receptors.
Lorenzon P; Vecile E; Nardon E; Ferrero E; Harlan JM; Tedesco F; Dobrina A
J Cell Biol; 1998 Sep; 142(5):1381-91. PubMed ID: 9732297
[TBL] [Abstract][Full Text] [Related]
18. Interference of nonsteroidal antiinflammatory drugs with very late activation antigen 4/vascular cells adhesion molecule 1-mediated lymphocyte-endothelial cell adhesion.
González-Alvaro I; Muñoz C; García-Vicuña R; Sabando P; Cabañas C; Sánchez-Madrid F; Díaz-González F
Arthritis Rheum; 1998 Sep; 41(9):1677-88. PubMed ID: 9751102
[TBL] [Abstract][Full Text] [Related]
19. Migration of skin-homing T cells across cytokine-activated human endothelial cell layers involves interaction of the cutaneous lymphocyte-associated antigen (CLA), the very late antigen-4 (VLA-4), and the lymphocyte function-associated antigen-1 (LFA-1).
Santamaria Babi LF; Moser R; Perez Soler MT; Picker LJ; Blaser K; Hauser C
J Immunol; 1995 Feb; 154(4):1543-50. PubMed ID: 7836740
[TBL] [Abstract][Full Text] [Related]
20. Vascular cell adhesion molecule (VCAM)-Ig fusion protein defines distinct affinity states of the very late antigen-4 (VLA-4) receptor.
Jakubowski A; Rosa MD; Bixler S; Lobb R; Burkly LC
Cell Adhes Commun; 1995 May; 3(2):131-42. PubMed ID: 7583006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
